Metraipolis › archive › dc_5561ecb8ec53

Cytogenetic and molecular characterization of an atypical ETP-ALL case with BCL2 dependency: therapeutic implications for Venetoclax use — Europe PMC PMID:40965810

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40965810
DOI
10.1007/s11033-[numero omesso]-1
License (as archived)
solo-consultazione
Archived
2026-11-09T21:02:35.769Z
SHA-256 of the archived text
58e79c48c2cae56336ce2d75d88c88e337c854206c36b14b9e6d02673a8f51f9
Stable URL of this page
https://metraipolis.com/documento/dc_5561ecb8ec53

How to cite

Cytogenetic and molecular characterization of an atypical ETP-ALL case with BCL2 dependency: therapeutic implications for Venetoclax use — Europe PMC PMID:40965810 — Europe PMC (en), https://europepmc.org/article/MED/40965810 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5561ecb8ec53 (Metraipolis archive dc_5561ecb8ec53, sha256 58e79c48c2cae56336ce2d75d88c88e337c854206c36b14b9e6d02673a8f51f9)
BibTeX
@misc{dc5561ecb8ec53,
  title = {Cytogenetic and molecular characterization of an atypical ETP-ALL case with BCL2 dependency: therapeutic implications for Venetoclax use — Europe PMC PMID:40965810},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40965810},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5561ecb8ec53; sha256 58e79c48c2cae56336ce2d75d88c88e337c854206c36b14b9e6d02673a8f51f9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40965810. Agents can read the archived copy with the MCP tool read_document.